Patents by Inventor Leif Kirsebom

Leif Kirsebom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-infective heterocyclic compounds and uses thereof
    Patent number: 11130741
    Abstract: The present invention relates to heterocyclic compounds of Formula I useful as anti-infective agents. The present invention further relates to a method of treating an infection by administering such compounds, and to pharmaceutical compositions comprising such compounds.
    Type: Grant
    Filed: June 22, 2017
    Date of Patent: September 28, 2021
    Assignee: Bioimics AB
    Inventors: Leif Kirsebom, Ram Shankar Upadhayaya, Raghava Reddy Kethiri, Anders Virtanen
  • ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20210246115
    Abstract: The present invention relates to heterocyclic compounds of Formula F-I useful as anti-infective agents. The present invention further relates to a method of treating an infection by administering such compounds, and to pharmaceutical compositions comprising such compounds.
    Type: Application
    Filed: November 5, 2018
    Publication date: August 12, 2021
    Inventors: Leif Kirsebom, Ram Shankar Upadhayaya, Raghava Reddy Kethiri, Anders Virtanen
  • ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20190233384
    Abstract: The present invention relates to heterocyclic compounds of Formula I useful as anti-infective agents. The present invention further relates to a method of treating an infection by administering such compounds, and to pharmaceutical compositions comprising such compounds.
    Type: Application
    Filed: June 22, 2017
    Publication date: August 1, 2019
    Inventors: Leif Kirsebom, Ram Shankar Upadhayaya, Raghava Reddy Kethiri, Anders Virtanen
  • VACCINE FOR THE TREATMENT OF MYCOBATERIUM RELATED DISORDERS
    Publication number: 20140335536
    Abstract: The invention relates to genes and proteins involved in the sporulation of Mycobacteria and the use thereof in the technical fields of immunology and medicine.
    Type: Application
    Filed: May 28, 2014
    Publication date: November 13, 2014
    Applicant: MARFL AB
    Inventors: Leif KIRSEBOM, Santanu DASGUPTA, Pontus LARSSON, Jaydip GHOSH
  • Vaccine for the treatment of related disorders
    Patent number: 8779088
    Abstract: The invention relates to genes and proteins involved in the sporulation of Mycobacteria and the use thereof in the technical fields of immunology and medicine. A vaccine comprising spore forming peptides, such as CotA or CotD, or antibodies thereto is used for the treatment of diseases caused by Mycobacterium such as leprosy and tuberculosis.
    Type: Grant
    Filed: December 17, 2008
    Date of Patent: July 15, 2014
    Assignee: Marfl AB
    Inventors: Leif Kirsebom, Santanu Dasgupta, Pontus Larsson, Jaydip Ghosh
  • METHOD FOR DETECTION OF PATHOGENIC ORGANISMS
    Publication number: 20140018445
    Abstract: A method for detection of pathogenic organisms wherein the method includes differentiation between species. The method is especially suitable to detect and to diagnose infection by pathogenic organisms which are hard and/or laborious to detect with conventional methods. The method relies upon analysis of specific variable regions of the RNase P RNA gene, namely the P3 and/or P19 region(s).
    Type: Application
    Filed: January 2, 2013
    Publication date: January 16, 2014
    Inventors: Björn HERRMANN, Leif KIRSEBOM, Pelle STOLT
  • Method for detection of pathogenic organisms
    Patent number: 8367321
    Abstract: A method for detection of pathogenic organisms wherein the method includes differentiation between species. The method is especially suitable to detect and to diagnose infection by pathogenic organisms which are hard and/or laborious to detect with conventional methods. The method relies upon analysis of specific variable regions of the RNase P RNA gene, namely the P3 and/or P19 region(s).
    Type: Grant
    Filed: January 10, 2001
    Date of Patent: February 5, 2013
    Inventors: Bjorn Herrmann, Leif Kirsebom, Pelle Stolt
  • NEW VACCINE FOR THE TREATMENT OF MYCOBACTERIUM RELATED DISORDERS
    Publication number: 20110104180
    Abstract: The invention relates to genes and proteins involved in the sporulation of Mycobacteria and the use thereof in the technical fields of immunology and medicine. A vaccine comprising spore forming peptides, such as CotA or CotD, or antibodies thereto is used for the treatment of diseases caused by Mycobacterium such as leprosy and tuberculosis.
    Type: Application
    Filed: December 17, 2008
    Publication date: May 5, 2011
    Inventors: Leif Kirsebom, Santanu Dasgupta, Pontus Larsson
  • Method and kit for detection of novel pathogen inhibitors
    Patent number: 7794967
    Abstract: The present invention relates to a method for detection of novel pathogen inhibitors using models of pathogen specific, and metal binding structures/domains representing essential cellular molecules. The method enables identification of inhibitors that bind to any specific RNA molecule or protein that are essential for cell growth, proliferation and differentiation. The invention also relates to a kit for use in the method. Furthermore, the invention relates to use of aminoglycosides in the development of new drugs.
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: September 14, 2010
    Assignee: Bioimics AB
    Inventors: Anders Virtanen, Leif Kirsebom
  • Method for detection of pathogenic organisms
    Publication number: 20030134295
    Abstract: A method for detection of pathogenic organisms wherein the method includes differentiation between species. The method is especially suitable to detect and to diagnose infection by pathogenic organisms which are hard and/or laborious to detect with conventional methods. The method relies upon analysis of specific variable regions of the RNase P RNA gene, namely the P3 and/or P19 region(s).
    Type: Application
    Filed: November 13, 2002
    Publication date: July 17, 2003
    Inventors: Bjorn Herrmann, Leif Kirsebom, Pelle Stolt